article thumbnail

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. 2021 [6] Regina M.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

The exhilarating pace of change is evidenced at Cera, a digital-first home healthcare enterprise that has seen the patient visits that drive its processes increase from 120,000 in 2019 to 18 million in 2023. Digital health companies can help identify new drug targets, design clinical trials and analyse data more effectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

2022: Teladoc faces challenges in the market for digital health. 2023: Teladoc's stock price falls significantly. These devices collect data about the user's health, which is then sent to Livongo's platform. Livongo's platform has been shown to be effective in helping people with chronic conditions manage their health.

article thumbnail

Unveiling the Transformative Power: Benefits of AI in Healthcare in 2024

DrKumo Remote Patient Monitoring

during the period from 2023 to 2032. AI, or Artificial Intelligence, in healthcare refers to the use of advanced computer algorithms and data analytics to improve various aspects of medical care and administration. This allows for precision medicine tailored to the individual’s unique health profile.